Avantor Expands St Louis Quality Control Capabilities To Accelerate Biopharma Manufacturing

17 April 2026 | Friday | News


Integrated microbial and stability testing enhances turnaround times, strengthens supply chain control, and brings GMP aligned quality infrastructure closer to United States based production operations

St. Louis site strengthens integrated support for biopharma manufacturing

Avantor, Inc, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the expansion of its North American quality control capabilities with the addition of advanced microbial and stability testing at its St. Louis manufacturing site.

The investment builds on Avantor's established global quality infrastructure, expanding and localizing capabilities to better support U.S.-based biopharma manufacturing and further accelerate service for customers.

Key Highlights

  • Expands GMP-aligned microbial testing and ICH-compliant stability testing and storage in North America
  • Localizes testing previously conducted across third-party labs and Avantor's global network, bringing critical capabilities closer to U.S. manufacturing operations
  • Supports 2,000+ microbial samples annually within Avantor's internal network
  • Enables faster turnaround times, improved data visibility, and reduced supply chain complexity

Expanding and Consolidating U.S. Quality Infrastructure
The enhanced St. Louis facility now offers integrated microbial and stability testing aligned with global regulatory standards, supporting regulated biopharma applications and reinforcing Avantor's commitment to quality, compliance, and customer service.

By consolidating these capabilities into a single North American location, Avantor reduces reliance on external laboratories and minimizes cross-border sample movement, improving efficiency while maintaining consistent global quality standards.

Improving Speed, Control and Supply Chain Efficiency
Integrating testing into one location enables accelerated time to market, more interconnected lab compliance and in-house expertise, and more streamlined operations across the biopharma supply chain.

Leadership Perspective
"Expanding our quality control capabilities in North America strengthens our manufacturing and supply chain infrastructure and will help us deliver our high-quality chemicals and other products to customers faster," said Mary Blenn, Chief Operating Officer at Avantor. "As part of our Revival program, we are making significant investments in our global supply chain and quality capabilities, all with a focus on reducing risk, accelerating timelines and delivering more value to our customers."

Facility Designed for Compliance and Transparency
The facility is designed to support customer transparency and regulatory needs, including audit-ready laboratory space, advanced stability storage for high-value materials such as APIs and excipients, and capabilities that support more efficient, centralized testing and faster product development timelines.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close